Interview with Hervé Dussart , President, AstraZeneca Turkey
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Address: Büyükdere Cad. Yapı Kredi Plaza, B Blok, K:2-4, 34330 Levent – Istanbul / Turkey
,Turkey
Tel: +90 212 317 2300
Web: http://www.astrazeneca.com.tr/
Since 1999 with the mission to produce ideas that add value for the life of people spend their lives working for better quality, and performs a lot of research, AstraZeneca, has been undertaking major projects in Turkey within the framework of social responsibility . AstraZeneca to gain awareness of first aid at a young age, ‘First Aid’ project TOÇEV throughout Turkey and in conjunction with the Ministry of National Education conducts. Investigating the effects of socioeconomic and environmental factors on human health and will continue for 10 years, ‘Prospective Urban and Rural Epidemiology’ ‘PURE’ gold sponsor of the research all over the world. Continued under the leadership of our country, METSEND’in approximately 3000 people were included in this project. not only the disease-causing diseases, and investigating the causes and environments that support the work of public awareness in order to eliminate these causes, AstraZeneca, ‘Fast Forward-fast-forward’ approach, using the maximum to produce beneficial drugs, the patient needs to provide the most appropriate solutions and business processes through the developing world to adapt the driving force attack is considered.
AstraZeneca, research, development, prescription drugs, production, marketing and presentation of these services in the field, one of the most important international companies. Volume of $ 33 billion health care and chest infection, cardiology, gastroentereloji, oncology, central nervous system and leading position in diabetes care products offered by area is one of the world’s leading pharmaceutical companies
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
A recent arrival from China, Lilly’s Turkey MD Daniel Lucas assesses the country’s healthcare system and raises key questions about the sustainability of the system at large going forward, and…
MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and managing director Hatice Demiray has prioritized initiatives such as reducing internal bureaucracy…
GSK’s VP and Area GM Pharmaceuticals, Turkey and Caucasus, and chairman of Turkey’s innovative pharmaceutical association, discusses the effectiveness of the government’s current strategy for reducing the trade deficit in…
Imuneks is currently operating in the OTC market, but with three supergeneric products ready to market on the RX side, the firm has the potential to soon become one of…
Recordati’s South East regional VP, based in Istanbul, discusses Recordati Turkey’s key role as a manufacturing hub for Recordati, the importance of the Turkish market (fourth largest globally for the…
Turkey is quickly becoming a regional hub for pharmaceutical industry for management, clinical trials and manufacturing, explains the general manager of Chiesi Turkey. How important is it for the government…
Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better fit the contemporary Turkish environment. What attracted…
The general manager of Daiichi Sankyo Turkey discusses his affiliate’s expansion into a regional hub, current strategies for growth in the Turkish market, and the keys behind his affiliates multiple ‘great…
Turkey’s leading pharmaceutical company is in the process of developing production facilities abroad, and it has just begun construction of a USD 100 million biotech facility; CEO Süha Taşpolatoğlu believes…
The leadership of Turkey’s newest major pharmaceutical player, Pharmactive, discuss the firm’s two pronged growth strategy, detailing their own sales objectives and prospects, as well as the opportunities that they…
Polifarma is Turkey’s largest producer of basic parenteral IV solutions with a 41 percent market share the country and growing exports across the region. According to the Chairman and CEO…
Murat Barlas, the longest serving board member for the Turkish Pharmaceutical Manufacturers Association, discusses the need for a new perspective in government-industry relations in the Turkish pharmaceutical industry, and the…
See our Cookie Privacy Policy Here